Guanhao Biotech Co.,Ltd. (SHE:300238)
14.76
-0.23 (-1.53%)
Mar 30, 2026, 3:04 PM CST
Guanhao Biotech Revenue
In the year 2025, Guanhao Biotech had annual revenue of 387.75M CNY with 2.72% growth. Guanhao Biotech had revenue of 94.27M in the quarter ending December 31, 2025, a decrease of -5.11%.
Revenue
387.75M
Revenue Growth
+2.72%
P/S Ratio
10.25
Revenue / Employee
731.60K
Employees
530
Market Cap
3.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.75M | 10.27M | 2.72% |
| Dec 31, 2024 | 377.48M | -26.70M | -6.60% |
| Dec 31, 2023 | 404.18M | 26.89M | 7.13% |
| Jan 1, 2023 | 377.29M | -111.70M | -22.84% |
| Jan 1, 2022 | 488.98M | 52.02M | 11.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Pulike Biological Engineering | 1.10B |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Yantai Zhenghai Biotechnology | 347.60M |
| Shanghai Shen Lian Biomedical | 288.27M |
| Shanghai Obio Technology (Group) Corp. | 267.66M |